Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery

AAPS PharmSciTech

Volumn 10, Issue 3, 2009, Pages 985-992

  Pathak, Pankaj ^a   Nagarsenker, Mangal ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Lidocaine; Local anesthetic effect; Nanostructured lipid carriers (NLC); Solid lipid nanoparticle (SLN)

Indexed keywords

DRUG CARRIER; LIDOCAINE; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GUINEA PIG; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PARTICLE SIZE; PRICK TEST; SKIN; TRANSMISSION ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION;

ADMINISTRATION, TOPICAL; ANESTHETICS, LOCAL; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; EXCIPIENTS; GUINEA PIGS; LIDOCAINE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; SKIN ABSORPTION; X-RAY DIFFRACTION;

EID: 70449520102     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9287-1     Document Type: Article

References (25)

1. H Wei Y Chen L Xu J Zheng 2007 Percutaneous penetration kinetics of lidocaine and prilocaine in two local anesthetic formulations assessed by in vivo microdialysis in pigs Biol Pharm Bull 30 4 830 834 17409532 10.1248/bpb.30.830 1:CAS:528:DC%2BD2sXls1aku7o%3D (Pubitemid 46571011)
2. Rolland A. Particulate carriers in dermal and transdermal drug delivery: myth or reality? In: Rolland A, editor. Pharmaceutical particulate carriers-therapeutic applications. New York: Marcel Dekker; 1993. p. 367-417.
3. G Barratt 2003 Colloidal drug carriers: achievements and perspectives Cell Mol Life Sci 60 21 37 12613656 10.1007/s000180300002 1:CAS:528: DC%2BD3sXhvF2jtr4%3D (Pubitemid 36223115)
4. MH Schmid HC Korting 1996 Therapeutic process with topical liposome drugs for skin disease Adv Drug Deliv Rev 18 335 342 10.1016/0169-409X(95)00019-4 1:CAS:528:DyaK28XhtlWhs7k%3D (Pubitemid 26063307)
5. MS Nagarsenker AA Joshi 1997 Preparation, characterization and evaluation of liposomal dispersions of lidocaine Drug Dev Ind Pharm 23 12 1159 1165 10.3109/03639049709146153 1:CAS:528:DyaK1cXitVOm
6. M Kreilgaard EJ Pedersen JW Jaroszewski 2000 NMR characterisation and transdermal drug delivery potential of microemulsion systems J Control Release 69 421 433 11102682 10.1016/S0168-3659(00)00325-4 1:CAS:528:DC%2BD3cXotlart7c%3D (Pubitemid 30845486)
7. AC Sintov R Brandys-Sitton 2006 Facilitated skin penetration of lidocaine: combination of a short-term iontophoresis and microemulsion formulation Int J Pharm 316 58 67 16564144 10.1016/j.ijpharm.2006.02.034 1:CAS:528:DC%2BD28XkvVWrt7g%3D (Pubitemid 43765688)
8. Trumbore MW. A comparison of the rate and extent of lidocaine release from a novel topical anesthetic foam vs. a currently marketed lidocaine 4% cream. AAD Meeting February 2008.
9. RH Muller K Mader S Gohla 2000 Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art Eur J Pharm Biopharm 50 161 178 10840199 10.1016/S0939-6411(00)00087-4 1:CAS:528:DC%2BD3cXjslyisrg%3D (Pubitemid 30326695)
10. W Mehnert K Mader 2001 Solid lipid nanoparticles production, characterization and applications Adv Drug Deliv Rev 47 165 196 11311991 10.1016/S0169-409X(01)00105-3 1:CAS:528:DC%2BD3MXislGls7g%3D (Pubitemid 32324113)
11. SA Wissing RH Muller 2003 Cosmetic applications for solid lipid nanoparticles (SLN) Int J Pharm 254 65 68 12615411 10.1016/S0378-5173(02)00684-1 1:CAS:528:DC%2BD3sXhsFOrtrg%3D (Pubitemid 36259812)
12. CS Maia W Mehnert M Schaller HC Korting A Gysler A Haberland M Schäfer-Korting 2002 Drug targeting by solid lipid nanoparticles for dermal use J Drug Target 10 489 495 10.1080/1061186021000038364 1:CAS:528: DC%2BD38XosFyru7Y%3D (Pubitemid 35230199)
13. H Chen X Chang D Du W Liu J Liu T Weng Y Yang H Xu X Yang 2006 Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting J Control Release 110 296 306 16325954 10.1016/j.jconrel.2005.09.052 1:CAS:528:DC%2BD2MXhtlert7jK (Pubitemid 41827483)
14. LB Lopes DA Ferreira D Paula MJ Garcia JA Thomazini MA Fantini MB Bentley 2006 Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A Pharm Res 23 1332 1342 16715364 10.1007/s11095-006-0143-7 1:CAS:528:DC%2BD28XmtFCns7c%3D (Pubitemid 43946155)
15. J Liu W Hu H Chen Q Ni H Xu X Yang 2007 Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery Int J Pharm 328 191 195 16978810 10.1016/j.ijpharm.2006.08.007 1:CAS:528:DC%2BD28XhtlWqurbL (Pubitemid 44880576)
16. U Munster C Nakamura A Haberland K Jores W Mehnert S Rummel M Schaller HC Korting CC Zouboulis U Blume-Peytavi M Schäfer-Korting 2005 RU 58841-myristate-prodrug development for topical treatment of acne and androgenetic alopecia Pharmazie 60 8 12 15700772 1:STN:280: DC%2BD2M%2FntFGktA%3D%3D
17. V Iannuccelli N Sala R Tursilli G Coppi S Scalia 2006 Influence of liposphere preparation on butyl-methoxydibenzoylmethane photostability Eur J Pharm Biopharm 63 140 145 16531026 10.1016/j.ejpb.2006.01.007 1:CAS:528:DC%2BD28XltFCgs7s%3D (Pubitemid 43776210)
18. KA Shah AA Date MD Joshi VB Patravale 2007 Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery Int J Pharm 345 163 171 17644288 10.1016/j.ijpharm.2007.05.061 1:CAS:528:DC%2BD2sXhtlWnt7zF (Pubitemid 350087549)
19. RH Muller K Mader S Golha 2002 Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv Drug Deliv Rev 54 S131 155 12460720 10.1016/S0169-409X(02)00118-7 1:CAS:528:DC%2BD38XpsVOhtrc%3D (Pubitemid 35379959)
20. M Foldvari A Gesztes, et al. 1993 Topical liposomal local anesthetics: design, optimization and evaluation of formulations Drug Dev Ind Pharm 19 19 2499 2517 10.3109/03639049309047198 1:CAS:528:DyaK2cXhsVyhsg%3D%3D
21. RH Muller S Heinemann 1992 Fat emulsions for parenteral nutrition. I. Evaluation of microscopic and laser light scattering methods for the determination of the physical stability Clin Nutr 11 223 236 16840001 10.1016/0261-5614(92)90031-K 1:STN:280:DC%2BD28vhslymtQ%3D%3D
22. C Freitas RH Muller 1999 Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase Eur J Pharm Biopharm 47 125 132 10234536 10.1016/S0939-6411(98)00074-5 1:CAS:528:DyaK1MXjsValu7k%3D (Pubitemid 29185115)
23. 1H-NMR study Int J Pharm 205 15 21 11000538 10.1016/S0378-5173(00)00462-2 1:CAS:528: DC%2BD3cXmsFKru7Y%3D (Pubitemid 30734720)
24. V Jenning M Schäfer-Korting S Gohla 2000 Vitamin A loaded solid lipid nanoparticles for topical use: drug release properties J Control Release 66 115 126 10742573 10.1016/S0168-3659(99)00223-0 1:CAS:528:DC%2BD3cXhvF2lu7w%3D (Pubitemid 30160850)
25. C Freitas RH Muller 1999 Stability determination of solid lipid nanoparticles (SLN™) in aqueous dispersion after addition of electrolyte J Microencapsul 16 59 71 9972503 10.1080/026520499289310 1:CAS:528: DyaK1MXovF2rtw%3D%3D (Pubitemid 29045852)